Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enderle, M. D.
Right arrow Articles by Pfohl, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enderle, M. D.
Right arrow Articles by Pfohl, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 21, Issue 2 271-277, Copyright © 1998 by American Diabetes Association


ARTICLES

Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects

MD Enderle, N Benda, RM Schmuelling, HU Haering and M Pfohl
Department IV of Internal Medicine, University of Tubingen, Germany.

OBJECTIVE: To examine endothelial function (EF) noninvasively in IDDM and NIDDM patients with long diabetes duration. RESEARCH DESIGN AND METHODS: We studied EF in 17 IDDM patients without diabetic complications and in 25 NIDDM patients with comparable glycemic control and with diabetic complications and compared both with nondiabetic control subjects matched for age, sex, and lumen diameter. Using high-resolution ultrasound, we measured the endothelial-dependent (FAD%) and independent vasodilation (GTN%); the blood flow at rest, postocclusive, and after application of 400 micrograms glyceroltrinitrate of the branchial artery; and the intima media thickness (IMT) of the common carotid artery. RESULTS: In the IDDM patients, neither FAD% (8.2 +/- 4.6 vs. 7.6 +/- 4.2%), GTN% (16.3 +/- 4.9 vs. 18.4 +/- 6.4%), nor postocclusive blood flow (40.6 +/- 19.1 vs. 39.3 +/- 23.6 cm/s) differed from the control subjects. IMT (0.59 +/- 0.10 vs. 0.55 +/- 0.14 mm) was slightly, but not significantly, elevated. In contrast, the NIDDM patients showed an impaired FAD% (3.8 +/- 3.3 vs. 6.9 +/- 4.4%, P < 0.01), no difference in GTN%, and a decreased postocclusive blood flow (18.5 +/- 13.8 vs. 32.7 +/- 20.0 cm/s, P < 0.01). IMT was significantly increased in NIDDM patients (0.77 +/- 0.14 vs. 0.62 +/- 0.10 mm, P < 0.001). CONCLUSIONS: In contrast to NIDDM patients with cardiovascular complications, IDDM patients with long diabetes duration and good long-term metabolic control do not have impaired EF compared with control subjects.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
E. Gkaliagkousi, J. Ritter, and A. Ferro
Platelet-Derived Nitric Oxide Signaling and Regulation
Circ. Res., September 28, 2007; 101(7): 654 - 662.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Circulation, December 12, 2006; 114(24): 2710 - 2738.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Lautamaki, K.E. J. Airaksinen, M. Seppanen, J. Toikka, R. Harkonen, M. Luotolahti, R. Borra, J. Sundell, J. Knuuti, and P. Nuutila
Insulin Improves Myocardial Blood Flow in Patients With Type 2 Diabetes and Coronary Artery Disease
Diabetes, February 1, 2006; 55(2): 511 - 516.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. Cosson, I. Pham, P. Valensi, J. Paries, J.-R. Attali, and A. Nitenberg
Impaired Coronary Endothelium-Dependent Vasodilation Is Associated With Microalbuminuria in Patients With Type 2 Diabetes and Angiographically Normal Coronary Arteries
Diabetes Care, January 1, 2006; 29(1): 107 - 112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Skilton, N. T. Lai, K. A. Griffiths, L. M. Molyneaux, D. K. Yue, D. R. Sullivan, and D. S. Celermajer
Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1404 - H1410.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Jadhav, J Petrie, W Ferrell, S Cobbe, and N Sattar
Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation?
Heart, December 1, 2004; 90(12): 1379 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Natali, S. Baldeweg, E. Toschi, B. Capaldo, D. Barbaro, A. Gastaldelli, J. S. Yudkin, and E. Ferrannini
Vascular Effects of Improving Metabolic Control With Metformin or Rosiglitazone in Type 2 Diabetes
Diabetes Care, June 1, 2004; 27(6): 1349 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. De Cobelli, P. Fiorina, G. Perseghin, M. Magnone, M. Venturini, G. Zerbini, A. Zanello, G. Mazzolari, L. Monti, V. Di Carlo, et al.
L-Arginine-Induced Vasodilation of the Renal Vasculature Is Preserved in Uremic Type 1 Diabetic Patients After Kidney and Pancreas but not After Kidney-Alone Transplantation
Diabetes Care, April 1, 2004; 27(4): 947 - 954.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Fiorina, F. Folli, F. Bertuzzi, P. Maffi, G. Finzi, M. Venturini, C. Socci, A. Davalli, E. Orsenigo, L. Monti, et al.
Long-Term Beneficial Effect of Islet Transplantation on Diabetic Macro-/Microangiopathy in Type 1 Diabetic Kidney-Transplanted Patients
Diabetes Care, April 1, 2003; 26(4): 1129 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. K. Koh, M. H. Kang, D. K. Jin, S.-K. Lee, J. Y. Ahn, H. Y. Hwang, S. H. Yang, D. S. Kim, T. H. Ahn, and E. K. Shin
Vascular effects of estrogen in type II diabetic postmenopausal women
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1409 - 1415.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
A. M Storey, C. J Perry, and J. R Petrie
Review: Endothelial dysfunction in type 2 diabetes
The British Journal of Diabetes & Vascular Disease, August 1, 2001; 1(1): 22 - 27.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
O. Wendler, P. Landwehr, D. Bandner-Risch, T. Georg, and H.-J. Schafers
Vasoreactivity of arterial grafts in the patient with diabetes mellitus: investigations on internal thoracic artery and radial artery conduits
Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 305 - 311.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Fiorina, E. La Rocca, M. Venturini, F. Minicucci, I. Fermo, R. Paroni, A. D’Angelo, M. Sblendido, V. Di Carlo, M. Cristallo, et al.
Effects of Kidney-Pancreas Transplantation on Atherosclerotic Risk Factors and Endothelial Function in Patients With Uremia and Type 1 Diabetes
Diabetes, March 1, 2001; 50(3): 496 - 501.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. Perregaux, A. Chaudhuri, S. Rao, A. Airen, M. Wilson, B.-H. Sung, and P. Dandona
Brachial Vascular Reactivity in Blacks
Hypertension, November 1, 2000; 36(5): 866 - 871.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Balletshofer, K. Rittig, M. D. Enderle, A. Volk, E. Maerker, S. Jacob, S. Matthaei, K. Rett, and H. U. Haring
Endothelial Dysfunction Is Detectable in Young Normotensive First-Degree Relatives of Subjects With Type 2 Diabetes in Association With Insulin Resistance
Circulation, April 18, 2000; 101(15): 1780 - 1784.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M. Ryan, D. McInerney, D. Owens, P. Collins, A. Johnson, and G.H. Tomkin
Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity
QJM, February 1, 2000; 93(2): 85 - 91.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W. Bagg, G.D. Braatvedt, and N. Sharpe
A complex relationship: glucose, insulin and coronary artery disease
Eur. Heart J., January 1, 2000; 21(1): 8 - 9.
[PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Kawagishi, M. Matsuyoshi, M. Emoto, H. Taniwaki, H. Kanda, Y. Okuno, M. Inaba, E. Ishimura, Y. Nishizawa, and H. Morii
Impaired Endothelium-Dependent Vascular Responses of Retinal and Intrarenal Arteries in Patients With Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2509 - 2516.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. Wei, E. S. Freedland, J. Q. Purnell, and J. D. Brunzell
Excessive Weight Gain and Effects on Lipids With Intensive Therapy of Type 1 Diabetes
JAMA, December 16, 1998; 280(23): 1991 - 19921.
[Full Text] [PDF]


Home page
HeartHome page
M-D Enderle, S Schroeder, R Ossen, C Meisner, A Baumbach, H U Haering, K R Karsch, and M Pfohl
Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease
Heart, October 1, 1998; 80(4): 349 - 354.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.